Each of these markers were significantly downregulated in CAFs in KPCSmad4-KO tumors, while tumor-promoting CD90- myCAFs were increased (Fig. 4H-I; Supplementary Fig. 4J-N). This evidence concerns the gene THY1 and neoplasm.